Skip to main content
Log in

Hypoalbuminaemia and Naproxen Pharmacokinetics in a Patient with Rheumatoid Arthritis

  • Short Communication
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Ballantyne FC, Fleck A, Dick C. Albumin metabolism in rheumatoid arthritis. Annals of the Rheumatic Diseases 30: 265–270, 1971

    Article  PubMed  CAS  Google Scholar 

  • Baum J, Ziff M. Laboratory findings in rheumatoid arthritis. In Mc Carty DJ. Arthritis and allied conditions, pp. 643–659, Lea & Febiger, Philadelphia 1985

    Google Scholar 

  • Brogden RN, Pinder RM, Sawyer PR, Speight TM, Avery GS. Naproxen: a review of its pharmacological properties and therapeutic efficacy and use. Drugs 9: 326–363, 1975

    Article  PubMed  CAS  Google Scholar 

  • Day RO, Furst DE, Dromgoole SH, Kamm B, Roe R, et al. Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis. Clinical Pharmacology and Therapeutics 31: 733–740, 1982

    Article  PubMed  CAS  Google Scholar 

  • Gottlieb N, Smith PM, Smith EM. Pharmacodynamics of 197Au and 195Au labeled aurothiomalate in blood. Arthritis and Rheumatism 17: 171–183, 1974

    Article  PubMed  CAS  Google Scholar 

  • Reidenberg MM, Drayer DE. Alteration of drug-protein binding in renal disease. Clinical Pharmacokinetics 9 (Suppl. 1): 18–26, 1984

    Article  PubMed  Google Scholar 

  • Runkel R, Chaplin M, Sevelius H, Ortega E, Segre E. Pharmacokinetics of naproxen overdoses. Clinical Pharmacology and Therapeutics 20: 269–277, 1976

    PubMed  CAS  Google Scholar 

  • Scatchard G. The attractions of proteins for small molecules and ions. Annals of the New York Academy of Science 51: 660–672, 1949

    Article  CAS  Google Scholar 

  • Selley ML, Madsen BW, Thomas J. Protein binding of tolmetin. Clinical Pharmacology and Therapeutics 24: 694–705, 1978

    PubMed  CAS  Google Scholar 

  • Upton RA, Buskin JN, Williams RL, Holford NHG, Riegelman S. Negligible excretion of unchanged ketoprofen, naproxen and probenecid in urine. Journal of Pharmaceutical Sciences 69: 1254–1257, 1980

    Article  PubMed  CAS  Google Scholar 

  • Van Loenhout JWA, Van Ginneken CAM, Ketelaars HCJ, Kimenai PM, Tan Y, et al. A high-performance liquid Chromatographic method for the quantitative determination of naproxen and des-methyl-naproxen in biological samples. Journal of Liquid Chromatography 5: 549–561, 1982

    Article  Google Scholar 

  • Van Riel PLMC, Gribnau FWJ, Van De Putte LBA. Cell-bound gold in patients treated with aurothioglucose and auranofin. Journal of Rheumatology 10: 574–578, 1983

    PubMed  Google Scholar 

  • Verbeeck RK, Blackburn JL, Loewen GR. Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs. Clinical Pharmacokinetics 8: 297–331, 1983

    Article  PubMed  CAS  Google Scholar 

  • Wanwimolruk S, Birkett DJ, Brooks PM. Protein binding of some non-steroidal anti-inflammatory drugs in rheumatoid arthritis. Clinical Pharmacokinetics 7: 85–92, 1982

    Article  PubMed  CAS  Google Scholar 

  • Wilkinson P, Jeremy R, Brooks FP, Hollander JL. The mechanism of hypoalbuminaemia in rheumatoid arthritis. Annals of Internal Medicine 63: 109–114, 1965

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Den Ouweland, F.A., Gribnau, F.W.J., Tan, Y. et al. Hypoalbuminaemia and Naproxen Pharmacokinetics in a Patient with Rheumatoid Arthritis. Clin-Pharmacokinet 11, 511–515 (1986). https://doi.org/10.2165/00003088-198611060-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198611060-00007

Keywords

Navigation